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Abstract. Dengue virus (DENV) (Flavivirus, Flaviviridae) is a reemerging arthropod-borne virus with a worldwide
circulation, transmitted mainly by Aedes aegypti and Aedes albopictus mosquitoes. Since the first detection of its main
transmitting vector in 1992 and the invasion of DENV-1 in 1993, Costa Rica has faced dengue outbreaks yearly. In
2007 and 2013, Costa Rica experienced two of the largest outbreaks in terms of total and severe cases. To provide
genetic information about the etiologic agents producing these outbreaks, we conducted phylogenetic analysis of viruses
isolated from human samples. A total of 23 DENV-1 and DENV-2 sequences were characterized. These analyses signaled
that DENV-1 genotype V and DENV-2 American/Asian genotype were circulating in those outbreaks. Our results sug-
gest that the 2007 and 2013 outbreak viral strains of DENV-1 and DENV-2 originated from nearby countries and
underwent in situ microevolution.
Dengue is the most important emergent and reemergent
arboviral disease in tropical and subtropical regions. Dengue
virus (DENV) is a member of the genus Flavivirus of the
family Flaviviridae and has four antigenically distinct sero-
types (DENV 1–4). Each serotype is further classified into
four or five genotypes on the basis of their genetic diversity.1
Clinical presentations range from asymptomatic, undifferen-
tiated fever, and “classic” dengue to severe forms, such
as hemorrhagic fever and shock syndrome.2,3 Given the
geographical distribution of its main transmitting vector
Aedes aegypti, more than half of the world population is
at risk of infection. It is estimated that nearly 400 million
dengue infections and 500,000 severe dengue cases occur
worldwide annually.4 Interestingly, some genotypes and
certain lineages within genotypes have been more frequently
associated with severe disease outcomes.5,6 Therefore, to better
understand dengue outbreaks in hyperendemic regions, it
is important to thoroughly describe the genetic diversity of
circulating serotypes.
The first dengue outbreak reported in Costa Rica occurred
in 1993 with DENV-1 as the only circulating serotype.7 Since
then, dengue cases have been documented annually—a con-
sequence of the endemicity of Aedes vectors that sustain
local transmission.8 Epidemiological and laboratory-based
surveillance suggests a pattern of serotype disappear and
reintroduction during the first decade after introduction.9 In
addition, sustained co-circulation of three serotypes (DENV-1,
DENV-2, and DENV-3) has been reported in later outbreaks,
making Costa Rica a hyperendemic country.9 Although den-
gue infections are always present in Costa Rica, peaks in
transmission events are observed every 2–5 years, similar to
other countries in the region.10 The largest dengue outbreak
in Costa Rica occurred in 2013, with almost 50,000 cases
suspected on the basis of laboratory testing and/or clinical
symptoms (taken together with epidemiological link to pre-
vious laboratory-confirmed cases from a particular area)
(Figure 1). Before 2013, there was a major outbreak in 2007.
Although it was apparently smaller (26,000 total reported
cases), more severe dengue cases (318 severe cases and eight
deaths) was observed. The latter were classified using the
National Ministry of Health criteria (based on existing World
Health Organization (WHO) criteria in 2007 and then the
new 2009 WHO criteria for the 2013). Despite the persistent
prevalence and impact of dengue in Costa Rica for almost
18 years, there is little knowledge about DENV genetics in
Costa Rica. Here, we present the molecular and phyloge-
netic characterization of dengue strains recovered from human
samples collected in the 2007 and 2013 major outbreaks in
Costa Rica.
To understand the genetic profile and possible origin of
circulating strains, we conducted analyses of the E protein
gene sequence. For this, whole blood samples were taken
from patients for virus isolation no more than 6 days after
fever onset. This study was approved by the Scientific Ethics
Committee of the University of Costa Rica (VI-5305-2015).
All patient identifiers were removed from blood samples
before analysis in the laboratory. Samples were inoculated
on to C6/36 cells and kept at 32–33°C until cytopathic effect
was apparent. Dengue isolates with a maximum of two
passages were obtained and analyzed from patients of the
2013 outbreak. Isolates from the 2007 outbreak with less
than four passages were generously donated by the National
Reference Center of Virology in the Costa Rican Institute
of Research and Teaching in Nutrition and Health. After
reverse transcription polymerase chain reaction confirmation
of dengue serotype, the aforementioned clinical isolates (pas-
sage two or four, respectively from 2013 or 2017 outbreaks)
were expanded and kept frozen at −70°C for other experi-
ments. A total of 23 DENV-1 and DENV-2 isolates were
characterized in this molecular study.
Viral RNAwas extracted using TRIzol Reagent® (Invitrogen,
Waltham, MA) from culture supernatants. Complementary
DNA (cDNA) was synthesized using the RevertAid™ H Minus
(ThermoFisher Scientific, Waltham, MA) following the manu-
facturer’s instructions with random primers. A seminested PCR
was performed using TopTaq Master Mix (Qiagen, Hilden,
Germany) and specific primers as described elsewhere.12 In
brief, PCR was implemented using cDNA and D1 and D2
primers, amplifying a product of 511 bp corresponding to
a fragment of the capsid and premembrane (C/prM) genes.
After serotype identification, cDNA segments between 2,474
and 2,577 nucleotides encompassing the prM and E genes of
DENV were amplified by PCR using the consensus primer
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D1 and serotype-specific reverse primers as described else-
where.13 PCR products were then purified using Exonuclease I
and FastAP Thermosensitive Alkaline Phosphatase treatment
(Thermo Fisher Scientific, Waltham, MA). Both strands of the
amplicons were sequenced using Sanger sequencing (Macrogen
Inc., Seoul, South Korea).
Previously described E protein gene sequence of geo-
graphically related strains of DENV-1 and DENV-2 were
obtained from GenBank for analyses. Multiple sequence
alignments were performed using Multiple Alignment using
Fast Fourier Transform in Geneious v8.1.7 (www.geneious
.com). Phylogenetic trees were assembled using the maxi-
mum likelihood statistical method based on GTR+G+I and
GTR+I for DENV-1 and DENV-2, respectively. The iden-
tification of the best nucleotide substitution model and the
construction of phylogenetic trees were performed using
MEGA v6.0 (www.megasoftware.com). The robustness of
the resulting tree was established by bootstrap analysis with
1,000 replications.
A total of 20 isolates of DENV-1 were successfully recov-
ered from both outbreaks. The phylogenetic tree retrieved
from the full E protein sequence of DENV-1 is shown in
Figure 2. A total of 91 DENV-1 sequences were used for this
analysis: 71 from GenBank and 20 new sequences from this
study (Supplemental Table 1). As shown in Figure 2, isolates
from Costa Rica are divided into two clades (1 and 2) corre-
sponding solely to genotype V. This genotype comprises
the majority of American and Caribbean strains.14 DENV-1
strains from 2013 outbreak (shown in bold) clustered in one
clade, is further subdivided into two subclades (a and b).
This suggests that the circulating viruses during this outbreak
were from at least two distinct sources. All sequences from
2013 clustered together with strains from neighboring coun-
tries, especially from Nicaragua. Sequences from 2005 and
2007 grouped in one of these subclades (a), suggesting that
some of the 2013 circulating virus originated from local
transmission and in situ microevolution. The sequences of
the other subclade (b) were more closely related to 2012
sequences reported from Nicaragua. This implies that some
of the 2013 outbreak strains from Costa Rica most likely
originated from virus circulating in neighboring Nicaragua
a year before. Furthermore, the phylogenetic tree displays a
pattern that suggests a replacement of the 1993 circulating
clade of DENV-1 (clade 2). Lineage extinction and replace-
ment is a well-described phenomenon in DENV evolution at
local levels.15 Nevertheless, a larger number of isolates would
need to be analyzed to confirm the extinction of this clade.
DENV-2 was not isolated from among the 2013 samples
included in this study, so for the DENV-2 analysis, only
the 2007 sequences generated in this study were included
in the final dataset of 76 DENV-2 E protein gene sequences
(73 from GenBank, three from 2007 viral strains) (Supple-
mental Table 2). The resulting phylogenetic tree is shown
in Figure 3. The three Costa Rican sequences from 2007
(shown in bold) were grouped in the American/Asian geno-
type, the principal circulating DENV-2 genotype in this
region.16 The 2007 isolates fell into two subclades (a and b),
indicating co-circulation of at least two lineages. As seen
for some DENV-1 strains of the 2013 outbreak, DENV-2
sequences from 2007 seem to be closely related to viruses
reported from Nicaragua a year before that were associated
with more severe cases.17 While it is tempting to speculate
that this strain might be more virulent and thus explain the
higher number of severe cases reported in 2007 in Costa
Rica, studies of the clinical outcome and immunological
backgrounds of patient would be necessary to confirm such a
hypothesis. Finally two sequences belonging to the American
genotype were reported from Costa Rica in 1994.18 It is plau-
sible that the strains of this genotype did not maintain their
circulation in the country, since DENV-2 was not detected
by laboratory-based surveillance until 1999 (Figure 1).19
This study revealed that the circulating genotypes of the
2007 and 2013 outbreaks in Costa Rica were closely related
to other DENVs found in the region. A larger number of
dengue isolates and further analysis considering viral genet-
ics, herd immunity, and geographical distribution are needed
to thoroughly understand dengue dynamics in Costa Rica.
Nevertheless, continuous monitoring of circulating strains is
crucial to detect the appearance of newer strains and their
role in dengue epidemiology in Costa Rica. The social and
commercial activity between countries of Central America
and their proximity means that exchange of virus strains is
inevitable. The present study therefore complements previ-
ous dengue molecular epidemiology research by providing
a more complete picture of dengue dynamics in Central
America. This can inform implementation of control mea-
sures and interventions to prevent impeding epidemics. In
addition, information on DENV molecular diversity is impor-
tant for the establishment of immunoprophylactic approaches
to control the disease in the region.
FIGURE 1. Reported dengue cases (black bars), severe dengue cases (continuous gray line), and circulating serotypes per year in Costa Rica.
These results were retrieved from epidemiological and laboratory-based surveillance done by the Ministry of Health.11
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FIGURE 2. Maximum likelihood tree of 91 DENV-1 E gene sequences (1,485 bp) including 24 Costa Rican strains (black rectangle), 20
obtained from this study (bold font), and four obtained from GenBank (italic font). Significant bootstrap values (≥ 70) are indicated at the
respecting nodes. The sequences were named according to reference number/country/year of collection or isolation. Major clades and subclades
comprising Costa Rican strains are indicated with numbers and letters, respectively.
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